Dirithromycin

地红霉素

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameDirithromycin
Drug Alias NameDirithromycinum迪利霉素DirithromycineDiritromicinaNoriclan +[12] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsAcute BronchitisUncomplicated skin and skin structure infectionsCommunity Acquired Pneumonia +[10] 
Global Approved IndicationsAcute BronchitisUncomplicated skin and skin structure infectionsCommunity Acquired Pneumonia +[10] 
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1995/06/19
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesHunan Jiudian Pharmaceutical Co Ltd
Inactive CompaniesLilly Research Laboratories
Active IndicationsBacterial Infections
Inactive IndicationsAcute BronchitisUncomplicated skin and skin structure infectionsCommunity Acquired Pneumonia +[9] 

Other Information

ATC CodeJ01FA13
Related LinksWikipediaDrugBankKEGG